XM8Q31ICD-11 MMS 2026-01
Drugs for treatment of lepra
Index terms
- Drugs for treatment of lepra
Child codes
Sibling codes
XM06Z9– SolasulfoneXM0AR8– ThioacetazoneXM18Y4– Benzoylpas calciumXM1FD5– DelamanidXM23G7– FenamisalXM2754– Calcium benzamidosalicylateXM2QH1– PasiniazidXM2ZK2– Isonicotinic acid hydrazideXM3070– Acetosulfone sodiumXM3307– Bromosalicylhydroxamic acidXM38J6– RifamideXM3BE3– Thiocarbamide derivativesXM3SD9– SulfonazideXM3SN8– SulfonesXM3UQ6– Potassium aminosalicylateXM3XE5– MethaniazideXM4611– PyrazinamideXM4GU0– RimifonXM4N96– EthambutolXM4Q32– PentylsalicylamideXM4RF4– Glucosulfone sodiumXM4TV0– Anti-infective antimycobacterialXM5FH2– IsoniazidXM5K63– Antimycobacterial drug combinationXM5MQ5– Thioacetazone with isoniazidXM60U0– BedaquilineXM62H2– TiocarlideXM64N2– Ethyl chaulmoograteXM6DX3– AntitubercularsXM6LM1– MorphazinamideXM6QT5– AminosalylumXM72Q4– Aldesulfone sodiumXM7945– GlyconiazideXM7AQ6– Antimycobacterial antibioticXM7SC9– SalinazidXM7TM4– ChaulmosulfoneXM8781– Aminosalicylic acid and derivativesXM8CP2– ProminXM8DJ8– PromacetinXM8UX1– MorinamideXM95S8– Cyanacetyl hydrazideXM99P0– ThiambutosineXM9TD0– Terizidone
Foundation entity
Drugs for treatment of lepra – http://id.who.int/icd/entity/1892703871
Part of: XM5MU9: Systemic antibiotics, anti-infectives or antiparasitics › XM6S30: Medicaments › X: Extension Codes